Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

NCT07437950 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

126

Enrollment

NIH

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
DRUG: Decitabine and Cedazuridine
DRUG: Venetoclax

Sponsor

National Cancer Institute (NCI)